PRECOM

This brand name is authorized in Nigeria.

Active ingredients

The drug PRECOM contains one active pharmaceutical ingredient (API):

1	Montelukast UNII MHM278SD3E - MONTELUKAST
	Montelukast is an orally active compound which binds with high affinity and selectivity to the CysLT1 receptor. Τhe CysLT type-1 (CysLT1) receptor is found in the human airway (including airway smooth muscle cells and airway macrophages) and on other pro-inflammatory cells (including eosinophils and certain myeloid stem cells). CysLTs have been correlated with the pathophysiology of asthma and allergic rhinitis.
	Read more about Montelukast

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-100773	Tablet	PRECOM TABLET MONTELUKAST 10MG TAB 10 mg 3x10	19 NF-PP-272105 PRECOM TABLET MONTELUKAST 10MG MONTELUKAST 10MG, MAGNESIUM STEARATE, CROSCAMMELOSE SODIUM, MICROCRYSTALLINE CELLULISE A4-100773 Drugs Imported Products 310 Prescription Only Medicine (POM) 6/22/2022 ANNYGOD PHARMACEUTICAL COMPANY LTD, 28 UKWULU STREET, AWADA OBOSI, ANAMBRA STATE BAFNA PHARMACEUTICAL LTD., NO. 147, MADHAVARAM REDHILLS HIGH ROAD, GRANTLYON VILLAGE, VADAKARI POST, CHENNAI-600 052. INDIA., India	27/03/2024

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
R03DC03	Montelukast	R Respiratory system → R03 Drugs for obstructive airway diseases → R03D Other systemic drugs for obstructive airway diseases → R03DC Leukotriene receptor antagonists
Discover more medicines within R03DC03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-100773